OLYMPUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,542 JPY | +2.25% |
|
+11.03% | +24.55% |
| May. 13 | Olympus' Attributable Profit Soars 69.1% in Fiscal 2024 | MT |
| May. 13 | Japanese shares fall ahead of earnings reports; rising yields weigh | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 | 936B 6.01B | Sales 2025 * | 997B 6.4B | Capitalization | 2,962B 19.02B |
|---|---|---|---|---|---|
| Net income 2024 | 243B 1.56B | Net income 2025 * | 119B 767M | EV / Sales 2024 | 2.75 x |
| Net cash position 2024 * | 78.83B 506M | Net cash position 2025 * | 130B 837M | EV / Sales 2025 * | 2.84 x |
| P/E ratio 2024 |
11.1
x | P/E ratio 2025 * |
24.9
x | Employees | 32,844 |
| Yield 2024 * |
0.71% | Yield 2025 * |
0.78% | Free-Float | 94.61% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | +2.25% | ||
| 1 week | +11.03% | ||
| Current month | +15.50% | ||
| 1 month | +14.97% | ||
| 3 months | +17.39% | ||
| 6 months | +16.13% | ||
| Current year | +24.55% |
1 week
2 388.00
2 567.50
1 month
2 125.502 567.50
Current year
1 935.502 567.50
1 year
1 782.002 567.50
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
755.003 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 17-03-31 |
Yasuo Takeuchi
CHM | Chairman | 67 | 80-03-31 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jimmy C. Beasley
BRD | Director/Board Member | 61 | 19-05-31 |
Sumitaka Fujita
BRD | Director/Board Member | 81 | 12-03-31 |
Gary Pruden
BRD | Director/Board Member | 62 | 22-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 32 M€ | +15.54% | ||
| 2.11% | 10 M€ | +16.22% | - | |
| 1.55% | 240 M€ | +17.87% | ||
| 1.23% | 28,258 M€ | +16.92% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 2,542 | +2.25% | 5,201,600 |
| 24-05-16 | 2,486 | +0.40% | 4,127,000 |
| 24-05-15 | 2,476 | -1.22% | 3,302,200 |
| 24-05-14 | 2,506 | -0.16% | 8,856,300 |
| 24-05-13 | 2,510 | +9.65% | 10,358,900 |
Delayed Quote Japan Exchange, May 17, 2024 at 02:00 am EDT
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
2024-08-06
- Q1 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
2,542
JPY
Average target price
2,541
JPY
Spread / Average Target
-0.03%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.55% | 19.06B | |
| +12.15% | 227B | |
| +14.90% | 197B | |
| +18.22% | 141B | |
| +29.15% | 110B | |
| +0.53% | 64.15B | |
| +16.92% | 53.72B | |
| +6.33% | 51.75B | |
| +10.93% | 45.2B | |
| +5.87% | 37.37B |
- Stock Market
- Equities
- 7733 Stock